Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
LSTA
LSTA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LSTA News
Investigation into Lisata's Transaction with Kuva Labs for Possible Fiduciary Breaches
1d ago
PRnewswire
Lisata Therapeutics to be Taken Private by Kuva Labs
1d ago
Benzinga
Lisata Therapeutics to be Acquired by Kuva Labs
3d ago
NASDAQ.COM
Lisata Therapeutics to be Acquired by Kuva Labs for $5.00 per Share
3d ago
Newsfilter
LISATA THERAPEUTICS INC - KUVA TO ACQUIRE LISATA FOR $5.00 PER SHARE IN CASH ALONG WITH ONE CVR PER SHARE
3d ago
moomoo
Investor Rights Law Firm Investigates Multiple Companies
Feb 12 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Feb 12 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
Feb 02 2026
Globenewswire
Investigations Launched into Multiple Company Acquisitions
Feb 02 2026
Globenewswire
Investor Rights Law Firm Investigates Multiple Companies
Jan 29 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Jan 29 2026
Globenewswire
Halper Sadeh LLC Investigates Potential Violations by Multiple Companies
Jan 28 2026
PRnewswire
Investigation of Investor Rights: SkyWater and Others
Jan 27 2026
Globenewswire
Monteverde Law Firm Investigates Multiple Acquisition Cases
Jan 27 2026
Globenewswire
Halper Sadeh Investigates Fairness of Lisata's $4.00 Sale to Kuva Labs
Jan 21 2026
Businesswire
Kuva Labs to Acquire Lisata Therapeutics at $4.00 per Share, Stock Soars 88%
Jan 21 2026
stocktwits
Show More News
